Kenzo Tribouillard/AFP via Getty Images
Share:
Latest updates on COVID-19:
- POLITICO: EU ends emergency phase of coronavirus pandemic
- ECDC: Transitioning beyond the acute phase of the COVID-19 pandemic: Approaches and tools used by a sample of EU countries in the transition and de-escalation phase – interim report
- The Lancet Infectious Diseases: The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations
- Pfizer and BioNTech submit application for US Emergency Use Authorization for a COVID-19 vaccine booster dose in children 5 through 11 years of age
- Valneva provides regulatory update on its inactivated COVID-19 vaccine candidate
- Arcturus announces self-amplifying COVID-19 mRNA vaccine candidate ARCT-154 meets primary efficacy endpoint in Phase 3 study
- Gilead Sciences: Veklury® (remdesivir) is first and only approved treatment for pediatric patients under 12 years of age with COVID-19
- Gilead Sciences: Several new studies presented at ECCMID 2022 confirm Veklury® (remdesivir) activity in treating COVID-19
- Health Policy Watch: Lack of COVID-19 testing is undermining global tracking – and uptake of the new antiviral drugs
*****************
Treatment Action Group (TAG) released two community guides on nirmatrelvir/ritonavir (Paxlovid) and molnupiravir (Lagevrio), all-oral outpatient treatments for COVID-19.
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.